PHARMACY

Rendell selects Rite Aid as site for CHIP information in Pa.

BY Michael Johnsen

HARRISBURG, Pa. Pennsylvania Gov. Edward Rendell on Tuesday chose Rite Aid to be the conduit for information on the state’s Children’s Health Insurance Program—Rite Aid stores throughout south central Pennsylvania will host registration booths Sept. 27 from 2 p.m. to 6 p.m.

“We’re working hard to make sure every parent understands that no family earns too much for their children to be covered by CHIP,” Rendell stated. “Through Cover All Kids, CHIP is now available to thousands of uninsured children whose parents who may have earned too much to qualify for coverage under the old guidelines.”

Under the new guidelines, some families qualify for free CHIP coverage while others may receive coverage at a low cost based on family income. CHIP enrollment increased to 164,485 in September, a growth of more than 11 percent since September 2006. More than 4,200 children who are now in CHIP would not have previously been eligible.

Participating Rite Aid Store locations include: 4299 Union Deposit Rd., Harrisburg; 2604 Linglestown Rd., Harrisburg; 3601 Walnut St., Harrisburg; 1137 Market St., Lemoyne; 5277 Simpson Ferry Rd., Mechanicsburg; 40-42 West Market St., York; 3615 East Market St., York (Springettsbury); 115 Leader Heights Rd., York; 4135 North George St. Extension, York (Manchester); 1200 West Market St., York; 59 North Queen St., Lancaster; 1130 Cumberland St., Lebanon.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

GSK flu vaccine facility in Quebec is nearly completed

BY Allison Cerra

QUEBEC CITY, Canada GlaxoSmithKline said that it is near completion of its Quebec City manufacturing facility, used to develop the company’s influenza vaccine.

After a two-year—and $199 million—investment to upgrade the manufacturing site, the location will increase the capacity of vaccine doses to 75 million per year, the company said. The expansion has also given way to providing this facility, and existing ones, new equipment and other innovative technologies to assure efficient production.

The company has also doubled the size of its vaccine workforce in Quebec City since January 2006.

“[This] announcement reinforces the key role that both Quebec and Canada play in GSK’s global vaccine business,” said Michel Baijot, vice president of Worldwide Strategic Alliances and Business Development, GlaxoSmithKline Biologicals, the company’s vaccine division. “Through this investment, Quebec and Canada will have an impact on global health by supporting countries in their influenza pandemic planning.”

According to GSK, the company supplies about 75% of the Canadian government’s seasonal flu vaccine purchases and will also provide Canada with a pandemic vaccine in the event of an influenza pandemic. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

FDARA attempt to limit citizens petitions not likely to have much effect, expert claims

BY Drew Buono

WASHINGTON According to Richard Silver, senior vice president of Equity Research for Lehman Brothers, the Food and Drug Administration’s Revitalization Act, which included language intended to limit the use of citizen petitions to block approvals of generic drugs, will not stop their use by brand companies, the FDA reported.

“Citizen’s petitions … we do not think they’re going to go away.  The backlog continues to grow,” Silver said last week during the Generic Pharmaceutical Association’s Annual Policy Conference in Washington, D.C. “We don’t think the citizen’s reforms will change the behavior of brand companies significantly.”

Two versions of the legislation are currently pending before a conference committee.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES